
Sheena Bhalla
Director, Thoracic Medical Oncology Clinical Operations · University of Texas Southwestern Medical Center
Credentials: · · · · · ·
History
Research
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Review · Nature Reviews Clinical Oncology · 2021 · 1,282 citations
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19
Thrombosis Research · 2020 · 78 citations
AXL Inhibitors: Status of Clinical Development
Review · Current Oncology Reports · 2023 · First of 2 authors · Corresponding · 48 citations

21 papers

12 papers

8 papers · 8 as a resident

7 papers

6 papers
- TJ
6 papers · 5 as a fellow
- VN
6 papers

5 papers · 4 as a fellow
Clinical trials
- 2021–2027
Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC
Principal investigator · Active not recruiting · Phase 2
University of Texas Southwestern Medical Center
- 2020–2026
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)


